Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Carcinoma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Carcinoma

Cancer Family

Carcinoma

CI-CAN-00000114Explore in graph →

7,363 active trials118 approved drugs1,149 evidence items

NCIt: C2916
DOID: 305
MeSH: D002277

Overview
Statistics
Survival
Genomics305
Variants & evidence1149
Drugs205
Trials25720
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

StatusAll Active (any)Completed 8,791 Recruiting 4,867 Unknown 4,230 Terminated 2,619 Active Not Recruiting 2,273 Not Yet Recruiting 1,618 Withdrawn 954 Enrolling By Invitation 135 Suspended 129 No Longer Available 42 Approved For Marketing 35 Available 23 Temporarily Not Available 4

PhaseAll Early Phase 1 392 N/A 3,621 Phase 1 5,495 Phase 2 11,045 Phase 3 2,627 Phase 4 386

No study matches these filters